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Modified Guiding Sheath.
Paul B. Haser, MD, Daniel I. Fremed, BA, and Alan M. Graham, MD,
UMDNJ-RWJMS, New Brunswick, NJ
Objectives: Carotid access for stenting can be problematic due to
anatomic variations and/or aortic arch pathology. For rare cases best treated
by direct puncture of the common carotid artery (CCA), there is added
difficulty due to ergonomic and angulation issues, even with surgical expo-
sure. A newly designed access sheath, the H2H Guiding Sheath, facilitates
short access surgery (SAS) and reduces arterial damage.
Methods: A porcine model was created under a patent design modifi-
cation to the standard introducer sheath: the H2H guiding sheath. This
allowed for near parallel insertion of the sheath directly into the CCA. A
control study was feasible by simultaneous cannulation of the other carotid
with standard sheath insertion (7F, 11-cm sheath, Terumo). Bilateral carotid
stenting with angioplasty (CAS) under antiembolic protection was per-
formed. The CCA was then harvested en bloc with the sheath still inside.
Microbiologic activity was measured using assays of the cellular repressor of
E1A activated genes (CREG) activity. Macroscopic and histologic examina-
tions were performed to assess intima and media trauma at the insertion site
and the contralateral wall from the puncture site.
Results: Twenty porcine carotid arteries were successfully cannulated,
and CAS was performed without incident. Immunostaining and Western
analysis both demonstrated marked down-regulation of CREG in the vas-
cular media of the control group compared with the H2H group. Direct
CCA examination and histologic evaluation noted increase trauma to the
intima and contralateral side of the arterial wall in the control group.
Thrombus was present at the sheath tip on 3 of 10 control standard, straight
sheaths and none on the H2H study arm (Fig).
Conclusions:Amodest modification of the standard introducer sheath
can produce significantly less arterial wall injury and reduce cell markers
responsible for cell proliferation, potentially decreasing intimal hyperplasia
postprocedure. Conversely, standard sheath insertion through the neck
produces CCA injury and increases the risk of thrombus at the catheter-
arterial interface. SAS for CAS may be feasible in cases where arch anatomy
or pathology prohibit the usual intervention utilizing the H2H Guiding
Sheath.
Correlation of Carotid Stump Pressure During Carotid Endarterec-
tomy and the Contralateral Carotid/Cerebral Collateral Flow: Results
from a Randomized Trial
Ali F. AbuRahma, MD, Patrick A. Stone, MD, Albeir Y. Mousa, MD,
StephenM. Hass, MD, L. Scott Dean, PhD, MBA, and Tammi Keiffer, RN,
Robert C. Byrd Health Sciences Center of West Virginia University,
Charleston, WVa
Objectives: The optimal method for predicting when carotid shunting
during carotid endarterectomy (CEA) is unnecessary is controversial. This
study analyzed the correlation of carotid stump pressure (CSP) and the
status of contralateral carotid/cerebral collaterals and determined whether
preoperative duplex ultrasound (DUS)/cerebral angiography (angio) can
predict when CEA can be done without shunting.
Methods:The study randomized 98 patients into routine shunting and
102 into selective shunting if systolic CSP during CEAwas40mmHg. All
patients had preoperative carotid DUS and 87 had angios, which were
evaluated for the presence of collateral flow from the contralateral carotid(CC) or posterior circulation through the anterior and/or posterior com-
municating arteries.
Results: The perioperative stroke rate was 1.5% in the whole group.
There was no correlation between preoperative symptoms and the status of
the CC (normal, stenosed, or occluded, P  .1898). The mean CSP was
inversely related to the severity of CC: 60, 57, 55, 56, and 38 mm Hg for
normal,50%, 50-69%, 70-99% stenosis, and occluded arteries, respectively
(P .005). There was a direct relation between the number of patients with
40 mm Hg CSP (shunted group) and severity of CC stenosis: 6 of 62
(10%), for normal carotid, 7 of 43 (16%) for  50% (OR, 1.82), 12 of 69
(17%) for 50%-69% stenosis (OR, 1.97), 3 of 10 (30%) for 70%-99% (OR, 4;
CI, .81-19.68), and 9 of 13 (70%) for occlusion (OR, 21; CI, 4.98-89.32; P
 .0001). None of the patients (0/56) with normal to 70% CC stenosis
with cross-filling had CSP of 40 mm Hg (no shunting was necessary). In
contrast, 9 of 17 patients (53%) with70% CC stenosis and no cross-filling
had CSP of40 mmHg (P .0001). Meanwhile, 6 of 7 (86%) with70%
CC stenosis and cross-filling vs 2 of 7 (29%) with70% CC stenosis and no
cross-filling had CSP of40mmHg (P .1026). Overall, 62 of 63 patients
(98%) with cross-filling vs 10 of 24 (42%) without cross-filling had a 40
CSP (P  .0001).
Conclusions: There was inverse correlation between CSP and severity
of CC stenosis, and patients with severe CC stenosis/occlusion were more
likely to be shunted. The presence of cross-filling with normal to 70% CC
stenosis was associated with CSP of 40 mm Hg in 100% of patients, who
would not be shunted in our series.
Scientific Session V
Changes in Patient Selection in Lower Extremity Bypass in New
England: Lower Risk, Better Outcomes
Philip Goodney, MD, Brian W. Nolan, MD, David H. Stone, MD, Andres
Schanzer, MD, David S. Likosky, MD, and Jack L. Cronenwett, MD,
Dartmouth Hitchcock Medical Center, Lebanon, NH
Introduction: Surgeons, payers, and providers have recently placed
increasing emphasis on risk assessment and outcomes reporting in vascu-
lar surgery. Accordingly, we studied the change in the risk profiles of
patients undergoing lower extremity bypass surgery (LEB) in New
England.
Methods: We studied 2337 patients who underwent 2676 LEB pro-
cedures in the Vascular Study Group of New England (VSGNE) between
2003 and 2009, examining changes in patient characteristics, operative
techniques, and outcomes. We compared results over time using nonpara-
metric tests of trend, survival analysis, and life-table analysis.
Results: Between 2003 and 2009, the proportion of patients under-
going LEB for claudication increased, and these patients were overall more
likely to have undergone a failed endovascular intervention before surgery
than patients with critical limb ischemia (CLI). However, the use of endo-
vascular interventions before LEB increased over time in patients with CLI.
Further, the use of adjunctive evidence-based medications increased over
time in both claudication andCLI patients. Using the objective performance
goal (OPG) criteria published by the SVS, among patients with CLI, the
proportion designated as clinical high-risk (18%), anatomic high-risk (48%),
and conduit high-risk (32%) remained stable over time. Lastly, no significant
changes occurred in bypass origin or target, conduit, or the use of comple-
tion studies. In outcomes, patients were less likely to return to the OR,
require excessive transfusion, or experience wound infection over time,
whereas other outcomes such as mortality, graft patency, and limb salvage
remained unchanged in our database.
Conclusion: Between 2003 and 2009, patients undergoing LEB were
more likely to have claudication, to be treated with appropriate medications,
and have undergone previous endovascular intervention. Although major
complications such as amputation, graft occlusion, or death have remained
similar over time, complications such as wound infection, return to the OR,
and need for transfusion have declined.
Variables Overall 2003 2009 P
Patient characteristics
Indication for surgery (claudication) 26% 17% 28% .001
Indication for surgery (CLI) 74% 82% 73% .001
PTA/stent before surgery
Claudication 28% 14% 25% .0001
CLI 21% 22% 30% .157
Medication use
Aspirin 71% 61% 76% .001
Plavix 9% 5% 13% .01
Statin 62% 44% 85% .001
-Blockers 82% 73% 82% .0001
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Variables Overall 2003 2009 P
Surgical outcomes
Return to OR 14% 16% 7% .0001
Blood transfusion 2 U 5% 8% 3% .041
Wound infection 5% 5% 3% .026
1-year amputation-free survival 94/79% 94/81% 92/78%a NS
1-year graft patency (claudication/
CLI)
91/84% 89/85% 95/90%a NS
1-year limb salvage (claudication/
CLI)
98/89% 99/89% 94/88%a NS
aValues used from 2008 to allow for capture of 1-year outcomes.
Outcomes Following Endovascular Intervention for Chronic Critical
Limb Ischemia by Rutherford Classification
Maciej L. Dryjski, MD, PhD, Monica O’Brien-Irr, MS, RN, Linda Harris,
MD, and Hasan Dosluoglu, MD, Kaleida Health, Buffalo, NY
Objective: This study evaluated outcomes after endovascular interven-
tion (EVI) for chronic critical limb ischemia (CLI) by Rutherford class
(RC4: rest pain; RC5: tissue loss).
Methods: The medical records of all EVI performed for RC 4-5 by
vascular surgeons at a single institution during a 3-year period were
reviewed for the following outcomes. Sustained clinical success (SCS)—
Rutherford Improvement Score (RIS): 2, without target extremity
revascularization (TER). In RC5 patients, patency until healing; healing
4 months without recurrence or new ulceration. Secondary sustained
clinical success (SSCS)—RIS: 2 with TER. In RC5 patients; patency
until healing; healing at any time during follow-up, without recurrent or
new ulceration. Data were analyzed using SPSS. Significance was estab-
lished at the 0.05 level.
Results: Of 106 EVI performed, 78 (74%) were RC5. There were 39
men (37%). Mean age was 73 12. Mean follow-up was 19 months (range,
1-44). Table I: Significant differences between RC4 and RC5 were found.
Outcomes were significantly better for RC-4. Table II: Independent predic-
tors of failure of SCS and SSCS in RC5 are shown: Table III. SSCS in RC5
patients with DM and CHF was 11%, 33% when either CHF or DM were
present and 72% when neither were present (P  .009).
Conclusions:Outcome after EVI for RC4 was significantly better than
for RC5, favoring early intervention. Limb salvage was acceptable in RC5
yet, SCS (early wound healing without TER) occurred in only 21%. Diabetes
and CHF were predictors of poor SSCS. Careful selection of patients may
improve outcome in RC5.
Table I.
RC Distal EVI DM Dialysis Current smoker
RC4 29% 32% 0% 57%
RC5 53% 58% 14% 32%
P .029 .020 .036 .023
Table II.
RC 24-mon survival 24-mon limb salvage SCS SSCS
RC4 84%  8% 100% 48% 85%
RC5 62%  7% 83%  4% 21% 39%
P .09 .026 .006 .001
Table III.
Outcome
Independent
predictor Odds ratio
Confidence
interval P
SCS DM 3.76 1.04—13.69 .04
SSCS DM 4.69 1.42—15.63 .011
SSCS CHF 4.07 0.99—16.67 .05Lesion and Device Characteristics That Predict Distal Embolization
During Percutaneous Lower Extremity Interventions
Gautam V. Shrikhande, MD,HafizHussain, MD, Sikander Khan,MD, Rajeev
Dayal, MD, Katherine Gallagher, MD, James F. Mckinsey, MD, and Nicholas
Morrissey, MD, Columbia University Medical Center, New York, NY
Objectives: Distal embolization (DE) during percutaneous lower ex-
tremity revascularization (LER)may cause severe clinical sequelae. To better
define DE, we investigated which lesion characteristics and treatment mo-
dalities increase the risk for embolization.
Methods: A prospective registry of LER from 2004-2009 was re-
viewed. All cases with runoff evaluated before and after intervention were
included. Angiograms and operative reports were reviewed for evidence of
DE. Rates of DE were analyzed with 2, and outcomes were analyzed by
log-rank analysis. The study included 2137 lesions.
Results: Tables I and II report DE rates for lesions/modalities. DE
rate was unchanged by runoff status and did not affect limb salvage. In 32 of
34 cases of DE, patency was restored before leaving the OR.
Conclusions: DE is a rare event that occurs more often with CSI and
Pathway devices. In-stent and complex native lesions are at higher risk for
DE. DE has no effect on limb salvage and is typically reversible with
endovascular techniques.
Scientific Session VI
Simultaneous TEVAR and EVAR is Feasible with Minimal Morbidity
and Mortality
Melissa L. Kirkwood, MD, Alberto Pochettino, MD, Ronald M. Fairman,
MD, Benjamin M. Jackson, MD, Joseph E. Bavaria, MD, and Edward Y.
Woo, MD, Hospital of the University of Pennsylvania, Philadelphia, Pa
Objective: To determine the results of simultaneous TEVAR and
EVAR.
Methods: Records were retrospectively reviewed. Seven patients (5
men; mean age, 73 years) underwent simultaneous TEVAR and EVAR
between 1999-2009 at a single center. All patients had concomitant thoracic
and abdominal aneurysms. The average diameters of the thoracic and
abdominal aneurysms were 6.6 and 6.3 cm, respectively. Three patients were
treated emergently, and the remainder had urgent indications for simulta-
neous repair. All patients had significant comorbidities (HTN, CAD, CHF,
smoking, COPD).
Results: Average procedural time was 165 minutes. Spinal drainage
and neuromonitoring was used in all cases. TEVAR was performed before
Table I. Incidence of distal embolization based on
treatment modality
Intervention Lesions Distal embolization
No. No. (%)
PTA 570 5 (0.87)
PTA  stent 740 5 (0.67)
Silverhawk ATH 736 14 (1.9)
Newer ATH devices (Pathway, CSI) 36 8 (22.2)a
Laser 55 2 (3.63)
Total 2137 34 (1.59)
aIndicates P  .05 compared with PTA.
Table II. Embolization by lesion type and TASC
Variable Lesions Distal embolization
No. No. (%)
Lesion type
Stenosis 1334 13 (0.97)
Occlusion 615 15 (2.4)a
In-stent stenosis 188 6 (3.19)a
Total 2137 34 (1.59)
TASC
A/B 929 8 (0.86)
C/D 1208 26 (2.15)a
Total 2137 34 (1.59)
aDenotes statistical significance (P  .05).EVAR. Access was through the common femoral arteries in five patients.
Two patients required direct cannulation of the iliac artery for delivery of the
